BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33957482)

  • 1. Tumor-targeting hyaluronic acid/fluorescent carborane complex for boron neutron capture therapy.
    Yamana K; Kawasaki R; Sanada Y; Tabata A; Bando K; Yoshikawa K; Azuma H; Sakurai Y; Masunaga SI; Suzuki M; Sugikawa K; Nagasaki T; Ikeda A
    Biochem Biophys Res Commun; 2021 Jun; 559():210-216. PubMed ID: 33957482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
    Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
    Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction.
    Kawasaki R; Oshige A; Yamana K; Hirano H; Nishimura K; Miura Y; Yorioka R; Sanada Y; Bando K; Tabata A; Yasuhara K; Miyazaki Y; Shinoda W; Nishimura T; Azuma H; Takata T; Sakurai Y; Tanaka H; Suzuki M; Nagasaki T; Ikeda A
    Chemistry; 2023 Dec; 29(72):e202302486. PubMed ID: 37792507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-decorated carborane-TAT conjugation nanomicelles: A potential boron agent with enhanced selectivity of tumor cellular uptake.
    Quan H; Fan L; Huang Y; Xia X; He Y; Liu S; Yu J
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111826. PubMed ID: 33984611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
    Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carborane-FAPI conjugate: A potential FAP-targeted boron agent with improved boron content.
    Zhang J; Wu Y; Lu W; Xiao Y; Liu S; Yu J
    Appl Radiat Isot; 2024 Jul; 209():111330. PubMed ID: 38657372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
    Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent Organic Polymer as a Carborane Carrier for Imaging-Facilitated Boron Neutron Capture Therapy.
    Shi Y; Fu Q; Li J; Liu H; Zhang Z; Liu T; Liu Z
    ACS Appl Mater Interfaces; 2020 Dec; 12(50):55564-55573. PubMed ID: 33327054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carborane bearing pullulan nanogel-boron oxide nanoparticle hybrid for boron neutron capture therapy.
    Kawasaki R; Hirano H; Yamana K; Isozaki H; Kawamura S; Sanada Y; Bando K; Tabata A; Yoshikawa K; Azuma H; Takata T; Tanaka H; Sakurai Y; Suzuki M; Tarutani N; Katagiri K; Sawada SI; Sasaki Y; Akiyoshi K; Nagasaki T; Ikeda A
    Nanomedicine; 2023 Apr; 49():102659. PubMed ID: 36822335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular delivery and passive tumor targeting of a self-assembled nanogel containing carborane clusters for boron neutron capture therapy.
    Kawasaki R; Sasaki Y; Akiyoshi K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):147-152. PubMed ID: 28039054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
    Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1.
    Tilly N; Olsson P; Hartman T; Coderre J; Makar M; Malmquist J; Sjöberg S; Pettersson J; Carlsson J; Glimelius B
    Radiother Oncol; 1996 Jan; 38(1):41-50. PubMed ID: 8850425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
    Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
    Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.
    Wang S; Blaha C; Santos R; Huynh T; Hayes TR; Beckford-Vera DR; Blecha JE; Hong AS; Fogarty M; Hope TA; Raleigh DR; Wilson DM; Evans MJ; VanBrocklin HF; Ozawa T; Flavell RR
    Mol Pharm; 2019 Sep; 16(9):3831-3841. PubMed ID: 31381351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphiphilic Polycarbonates from Carborane-Installed Cyclic Carbonates as Potential Agents for Boron Neutron Capture Therapy.
    Xiong H; Wei X; Zhou D; Qi Y; Xie Z; Chen X; Jing X; Huang Y
    Bioconjug Chem; 2016 Sep; 27(9):2214-23. PubMed ID: 27548011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and tumor-targeting evaluation of BS-CyP albumin nanoparticles modified with hyaluronic acid based on boron neutron capture therapy.
    Ye M; Li B; Shi W; Liu H; Wang Y; Chen W; Wang J; Wang G
    J Biomed Mater Res A; 2023 Aug; 111(8):1176-1184. PubMed ID: 36740897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes.
    Kueffer PJ; Maitz CA; Khan AA; Schuster SA; Shlyakhtina NI; Jalisatgi SS; Brockman JD; Nigg DW; Hawthorne MF
    Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6512-7. PubMed ID: 23536304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
    Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
    J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sweet Battle of the Epimers─Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy.
    Matović J; Bahrami K; Stockmann P; Sokka IK; Khng YC; Sarparanta M; Hey-Hawkins E; Rautio J; Ekholm FS
    Mol Pharm; 2023 Jun; 20(6):3127-3139. PubMed ID: 37134022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.